Skip Navigation

European Heart Journal 1987 8(12):1272-1280;
Copyright © 1987 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by BOISSEL, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BOISSEL, J.-P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 The European Society of Cardiology

Sub-grouping of post myocardial infarction patients according to their one-year death risk

J.-P. BOISSEL, J.-C. PEYRIEUX and The EPSIM RESEARCH GROUP*

Unité de pharmacologie Clinique, Höpital Neuro-Cardiologique 162 Avenue Lacassagne 69424, Lyon Cédex 3, France

Received 7 November 1986; revised 8 May 1987; .

J. P. Boissel, Unité de Pharmacologie Clinique, Hôpital Neuro-Cardiologique, 1162 Avenue Lacassague, 69424, Lyon Cedex 3, France.

This study was undertaken to investigate whether sub-grouping post myocardial infarction (M1) patients with various risks of death was possible. Data on 6900 consecutive patients with clinical sympstoms of acute M1 were collected prospectively within 48 h of their admission. Vital status at one year was obtained for all but 264 (3.8%) A total of 476 (7.2%) patients died within the first 7 days. Correlation of baseline historical, demographic, biological and ECG variables with total mortality was first investigated with univariate analysis. Fifty-three secondary risk factors (SRF) were identified, based on: (1) a P value for comparison between dead and alive lower than 0.02; (2) a minimum number of 100 subjects in each cell of the four-fold table. Based on this set of SRFs, two approaches were used to investigate the distribution of patients still alive at 8 days regarding the one-year mortality risk, and to assign them in three sub-groups of equal size of increasing risk compared with a logistic regression. Both approaches gave consistent findings. One third of the patients with the lowest risk of death within 12 months had an individual risk between 0% and 8%; the average mortality was 5–6% which represented 10.7% of the total number of deaths. The third swith the highest individual risks had an individual risks had an individual risk ranging from 17–19% to 100%, with an average mortality of 35–37%; they accounted for 66–67% of the total number of deaths. Thus it seems possible to identify sub-groups of post M1 patients with either low risk, or very high risk, or very high risk. Only the latter deserve attention for secondary prevention.

Key Words: Prognosis • myocardial infarction • one-year risk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
J.-P. Boissel
Individualizing Aspirin Therapy for Prevention of Cardiovascular Events
JAMA, December 9, 1998; 280(22): 1949 - 1950.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.